title: Combination chemotherapy in advanced pancreatic cancer: time to raise the white flag?
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Welch
authors.forename: Malcolm J
authors.initials: MJ
authors.lastname: Moore
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D000093542:Gemcitabine
chemical_list: D003841:Deoxycytidine; D000069287:Capecitabine; D066246:ErbB Receptors; D005472:Fluorouracil; D000093542:Gemcitabine